[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Nicotinamide Mononucleotide (NMN) Market Growth 2024-2030

May 2024 | 95 pages | ID: G82FE4B87181EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

The global Nicotinamide Mononucleotide (NMN) market size is projected to grow from US$ 401 million in 2024 to US$ 763 million in 2030; it is expected to grow at a CAGR of 11.3% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Nicotinamide Mononucleotide (NMN) Industry Forecast” looks at past sales and reviews total world Nicotinamide Mononucleotide (NMN) sales in 2023, providing a comprehensive analysis by region and market sector of projected Nicotinamide Mononucleotide (NMN) sales for 2024 through 2030. With Nicotinamide Mononucleotide (NMN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nicotinamide Mononucleotide (NMN) industry.

This Insight Report provides a comprehensive analysis of the global Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotinamide Mononucleotide (NMN) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotinamide Mononucleotide (NMN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotinamide Mononucleotide (NMN).

Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ?98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.

This report presents a comprehensive overview, market shares, and growth opportunities of Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Content ?98%
  • Content ?98%
Segmentation by Application:
  • Health Care Products
  • Cosmetics
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • GeneHarbor
  • Herbalmax
  • Genex Formulas
  • Mirailab Bioscience
  • Maac10 Formulas
  • EffePharm
  • Bontac
  • CELFULL
  • Kingdomway
Key Questions Addressed in this Report

What is the 10-year outlook for the global Nicotinamide Mononucleotide (NMN) market?

What factors are driving Nicotinamide Mononucleotide (NMN) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nicotinamide Mononucleotide (NMN) market opportunities vary by end market size?

How does Nicotinamide Mononucleotide (NMN) break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Nicotinamide Mononucleotide (NMN) by Country/Region, 2019, 2023 & 2030
2.2 Nicotinamide Mononucleotide (NMN) Segment by Type
  2.2.1 Content ?98%
  2.2.2 Content ?98%
2.3 Nicotinamide Mononucleotide (NMN) Sales by Type
  2.3.1 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
  2.3.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024)
2.4 Nicotinamide Mononucleotide (NMN) Segment by Application
  2.4.1 Health Care Products
  2.4.2 Cosmetics
  2.4.3 Others
2.5 Nicotinamide Mononucleotide (NMN) Sales by Application
  2.5.1 Global Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
  2.5.2 Global Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024)

3 GLOBAL BY COMPANY

3.1 Global Nicotinamide Mononucleotide (NMN) Breakdown Data by Company
  3.1.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales by Company (2019-2024)
  3.1.2 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
3.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue by Company (2019-2024)
  3.2.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024)
  3.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
3.3 Global Nicotinamide Mononucleotide (NMN) Sale Price by Company
3.4 Key Manufacturers Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nicotinamide Mononucleotide (NMN) Product Location Distribution
  3.4.2 Players Nicotinamide Mononucleotide (NMN) Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION

4.1 World Historic Nicotinamide Mononucleotide (NMN) Market Size by Geographic Region (2019-2024)
  4.1.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Nicotinamide Mononucleotide (NMN) Market Size by Country/Region (2019-2024)
  4.2.1 Global Nicotinamide Mononucleotide (NMN) Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nicotinamide Mononucleotide (NMN) Sales Growth
4.4 APAC Nicotinamide Mononucleotide (NMN) Sales Growth
4.5 Europe Nicotinamide Mononucleotide (NMN) Sales Growth
4.6 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Growth

5 AMERICAS

5.1 Americas Nicotinamide Mononucleotide (NMN) Sales by Country
  5.1.1 Americas Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
  5.1.2 Americas Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
5.2 Americas Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
5.3 Americas Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nicotinamide Mononucleotide (NMN) Sales by Region
  6.1.1 APAC Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024)
  6.1.2 APAC Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024)
6.2 APAC Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
6.3 APAC Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nicotinamide Mononucleotide (NMN) by Country
  7.1.1 Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
  7.1.2 Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
7.2 Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
7.3 Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) by Country
  8.1.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
8.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
8.3 Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN)
10.3 Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
10.4 Industry Chain Structure of Nicotinamide Mononucleotide (NMN)

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nicotinamide Mononucleotide (NMN) Distributors
11.3 Nicotinamide Mononucleotide (NMN) Customer

12 WORLD FORECAST REVIEW FOR NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION

12.1 Global Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
  12.1.1 Global Nicotinamide Mononucleotide (NMN) Forecast by Region (2025-2030)
  12.1.2 Global Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Nicotinamide Mononucleotide (NMN) Forecast by Type (2025-2030)
12.7 Global Nicotinamide Mononucleotide (NMN) Forecast by Application (2025-2030)

13 KEY PLAYERS ANALYSIS

13.1 GeneHarbor
  13.1.1 GeneHarbor Company Information
  13.1.2 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
  13.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 GeneHarbor Main Business Overview
  13.1.5 GeneHarbor Latest Developments
13.2 Herbalmax
  13.2.1 Herbalmax Company Information
  13.2.2 Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
  13.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Herbalmax Main Business Overview
  13.2.5 Herbalmax Latest Developments
13.3 Genex Formulas
  13.3.1 Genex Formulas Company Information
  13.3.2 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
  13.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Genex Formulas Main Business Overview
  13.3.5 Genex Formulas Latest Developments
13.4 Mirailab Bioscience
  13.4.1 Mirailab Bioscience Company Information
  13.4.2 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
  13.4.3 Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Mirailab Bioscience Main Business Overview
  13.4.5 Mirailab Bioscience Latest Developments
13.5 Maac10 Formulas
  13.5.1 Maac10 Formulas Company Information
  13.5.2 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
  13.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Maac10 Formulas Main Business Overview
  13.5.5 Maac10 Formulas Latest Developments
13.6 EffePharm
  13.6.1 EffePharm Company Information
  13.6.2 EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
  13.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 EffePharm Main Business Overview
  13.6.5 EffePharm Latest Developments
13.7 Bontac
  13.7.1 Bontac Company Information
  13.7.2 Bontac Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
  13.7.3 Bontac Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Bontac Main Business Overview
  13.7.5 Bontac Latest Developments
13.8 CELFULL
  13.8.1 CELFULL Company Information
  13.8.2 CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
  13.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 CELFULL Main Business Overview
  13.8.5 CELFULL Latest Developments
13.9 Kingdomway
  13.9.1 Kingdomway Company Information
  13.9.2 Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
  13.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Kingdomway Main Business Overview
  13.9.5 Kingdomway Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Content ?98%
Table 4. Major Players of Content ?98%
Table 5. Global Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 6. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Table 7. Global Nicotinamide Mononucleotide (NMN) Revenue by Type (2019-2024) & ($ million)
Table 8. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Table 9. Global Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024) & (US$/Kg)
Table 10. Global Nicotinamide Mononucleotide (NMN) Sale by Application (2019-2024) & (Tons)
Table 11. Global Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
Table 12. Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & ($ million)
Table 13. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2024)
Table 14. Global Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024) & (US$/Kg)
Table 15. Global Nicotinamide Mononucleotide (NMN) Sales by Company (2019-2024) & (Tons)
Table 16. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
Table 17. Global Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
Table 19. Global Nicotinamide Mononucleotide (NMN) Sale Price by Company (2019-2024) & (US$/Kg)
Table 20. Key Manufacturers Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area
Table 21. Players Nicotinamide Mononucleotide (NMN) Products Offered
Table 22. Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Nicotinamide Mononucleotide (NMN) Sales Market Share Geographic Region (2019-2024)
Table 27. Global Nicotinamide Mononucleotide (NMN) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Nicotinamide Mononucleotide (NMN) Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019-2024)
Table 31. Global Nicotinamide Mononucleotide (NMN) Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 34. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Table 35. Americas Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 37. Americas Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 38. APAC Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024) & (Tons)
Table 39. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2019-2024)
Table 40. APAC Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 42. APAC Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 43. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 44. Europe Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 46. Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 50. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Nicotinamide Mononucleotide (NMN)
Table 52. Key Market Challenges & Risks of Nicotinamide Mononucleotide (NMN)
Table 53. Key Industry Trends of Nicotinamide Mononucleotide (NMN)
Table 54. Nicotinamide Mononucleotide (NMN) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Nicotinamide Mononucleotide (NMN) Distributors List
Table 57. Nicotinamide Mononucleotide (NMN) Customer List
Table 58. Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2025-2030) & (Tons)
Table 69. Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. GeneHarbor Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 73. GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 74. GeneHarbor Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 75. GeneHarbor Main Business
Table 76. GeneHarbor Latest Developments
Table 77. Herbalmax Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 78. Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 79. Herbalmax Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 80. Herbalmax Main Business
Table 81. Herbalmax Latest Developments
Table 82. Genex Formulas Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 83. Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 84. Genex Formulas Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 85. Genex Formulas Main Business
Table 86. Genex Formulas Latest Developments
Table 87. Mirailab Bioscience Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 88. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 89. Mirailab Bioscience Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 90. Mirailab Bioscience Main Business
Table 91. Mirailab Bioscience Latest Developments
Table 92. Maac10 Formulas Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 93. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 94. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 95. Maac10 Formulas Main Business
Table 96. Maac10 Formulas Latest Developments
Table 97. EffePharm Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 98. EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 99. EffePharm Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 100. EffePharm Main Business
Table 101. EffePharm Latest Developments
Table 102. Bontac Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bontac Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 104. Bontac Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 105. Bontac Main Business
Table 106. Bontac Latest Developments
Table 107. CELFULL Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 108. CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 109. CELFULL Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 110. CELFULL Main Business
Table 111. CELFULL Latest Developments
Table 112. Kingdomway Basic Information, Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 113. Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 114. Kingdomway Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 115. Kingdomway Main Business
Table 116. Kingdomway Latest Developments

LIST OF FIGURES

Figure 1. Picture of Nicotinamide Mononucleotide (NMN)
Figure 2. Nicotinamide Mononucleotide (NMN) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2023)
Figure 10. Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Content ?98%
Figure 12. Product Picture of Content ?98%
Figure 13. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2023
Figure 14. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Figure 15. Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products
Figure 16. Global Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2019-2024) & (Tons)
Figure 17. Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics
Figure 18. Global Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2019-2024) & (Tons)
Figure 19. Nicotinamide Mononucleotide (NMN) Consumed in Others
Figure 20. Global Nicotinamide Mononucleotide (NMN) Market: Others (2019-2024) & (Tons)
Figure 21. Global Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2023)
Figure 22. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2023
Figure 23. Nicotinamide Mononucleotide (NMN) Sales by Company in 2023 (Tons)
Figure 24. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Company in 2023
Figure 25. Nicotinamide Mononucleotide (NMN) Revenue by Company in 2023 ($ millions)
Figure 26. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2023
Figure 27. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 30. Americas Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 31. APAC Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 32. APAC Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 33. Europe Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 34. Europe Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 36. Middle East & Africa Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 37. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 38. Americas Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 39. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 40. Americas Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 41. United States Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2023
Figure 46. APAC Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2019-2024)
Figure 47. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 48. APAC Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 49. China Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 53. India Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 57. Europe Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 58. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 59. Europe Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 60. Germany Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 61. France Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 68. Egypt Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide (NMN) in 2023
Figure 74. Manufacturing Process Analysis of Nicotinamide Mononucleotide (NMN)
Figure 75. Industry Chain Structure of Nicotinamide Mononucleotide (NMN)
Figure 76. Channels of Distribution
Figure 77. Global Nicotinamide Mononucleotide (NMN) Sales Market Forecast by Region (2025-2030)
Figure 78. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2025-2030)


More Publications